SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001140361-19-007333
Filing Date
2019-04-18
Accepted
2019-04-18 16:15:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A nc10001159x1_sc13da.htm SC 13D/A 55421
  Complete submission text file 0001140361-19-007333.txt   57139
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Subject) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88750 | Film No.: 19756082
SIC: 2834 Pharmaceutical Preparations

Mailing Address 412 WEST 15TH STREET 9TH FLOOR NEW YORK NY 10011
Business Address 412 WEST 15TH STREET 9TH FLOOR NEW YORK NY 10011 646-597-6980
RTW INVESTMENTS, LP (Filed by) CIK: 0001493215 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A